Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Acta Biochimica Et Biophysica Sinica|December 24, 2025
Immune checkpoint TIM-3 in tumor immunotherapyShuaiya Ma, Mengyao Zhu, Chunhong Ma, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|November 22, 2021
Spatial distribution and functional analysis define the action pathway of Tim-3/Tim-3 ligands in tumor developmentTixiao Wang, Jie Zhang, Na Li, et al.Cancer Medicine|June 19, 2026
Association of Lipid and Inflammatory Profiles With Tumor Stage in Hepatocellular CarcinomaNanmu Yang, Ting Wang, Xiangjun Qian, et al.Frontiers in Oncology|January 23, 2026
Age-dependent prognostic significance of neutrophil-to-HDL ratio in hepatocellular carcinoma patientsQingjun Li, Ting Wang, Xiangjun Qian, et al.Science Immunology|November 15, 2024
Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunityZhaoying Zhang, Caiyue Ren, Rong Xiao, et al.Cell Reports. Medicine|August 21, 2024
Soluble Tim-3 serves as a tumor prognostic marker and therapeutic target for CD8<sup>+</sup> T cell exhaustion and anti-PD-1 resistanceChaojia Chen, Fangcheng Zhao, Jiali Peng, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 6, 2024
Urolithin A Hijacks ERK1/2-ULK1 Cascade to Improve CD8<sup>+</sup> T Cell Fitness for Antitumor ImmunityShuaiya Ma, Qi Wu, Wenxian Wu, et al.Science Translational Medicine|November 15, 2023
Identification of a small-molecule Tim-3 inhibitor to potentiate T cell-mediated antitumor immunotherapy in preclinical mouse modelsShuaiya Ma, Ye Tian, Jiali Peng, et al.Pageof 1